Thursday, September 12, 2013

J&J Recalls 5,000 Bottles of Risperdal Consta: Mold

Bloomberg Businessweek has;
J&J Recalls Some Schizophrenia Drug Vials After Mold Discovered
September 11, 2013

Johnson & Johnson (JNJ:US) is recalling 5,000 vials of its Risperdal Consta, a long-acting drug for patients with schizophrenia, after testing found the medicine was no longer sterile.
Routine analysis showed one lot of the injected drug was contaminated with alternaria alternata, a common mold found in the environment, said Robyn Reed Frenze, a spokeswoman for the New Brunswick, New Jersey-based company’s Janssen unit. There haven’t been any reports of complications among patients who received the medicine, though injection site reactions are possible, she said.
J&J, the world’s biggest seller of health products, has been plagued by recalls for several years. The company last week withdrew about 200,000 bottles of concentrated Motrin Infants’ Drops and is facing thousands of lawsuits following the recall of 93,000 ASR model hip implants in August 2010.
Thank You Bloomberg.

Continue reading Bloomberg coverage here.

No comments: